Draft resolutions for the General Meeting of Invalda AB Shareholders to be held on 14.11.2008 On the agenda:1. Regarding non-public LTL 25 m convertible bonds issue. 2. Regarding withdrawal for..
MoreOn the initiative and decision of the Board of Invalda AB (code 121304349,address Seimyniskiu str. 3, Vilnius) the agenda of General Shareholders Meeting, to be held on 14 November, 2008,..
MoreThe unaudited loss of financial sector companies of AB Invalda group for the first nine months of 2008 equalled LTL 14.7 million, whereas in the same period the previous year..
MoreThe companies of Invalda AB group finance sector experienced the loss of 14.7 mLTL (4.26 mEUR) for 9 months of 2008, whereas for the same period of 2007 the companies..
MoreSanitas AB received the information from its shareholder Invalda AB that it has executed definitive documentation to transfer a 20.3 % interest in Sanitas AB to Baltic Pharma Limited, an..
MoreThe Management Board and major shareholders of Sanitas AB (“Sanitas” or the “Company”) initiated a strategic review in April 2008, to consider various strategic options available to the Company to..
MoreOn October 24, 2008, Invalda AB has signed an agreement regarding transfer of 6 314 502 shares, i.e. 20.3 % of share capital, of Sanitas AB for the total price..
MoreCenter for Drug Administration and Research of U.S. Food and Drug Administration (FDA) after the inspection of sterile pharmaceutical finished dosage manufacturing facility in Polish pharmaceutical company Jelfa SA classified..
MoreNet profit of Vilniaus baldai AB during September 2008 was 477 thousand LTL (138 thousand EUR), September of previous year – net profit of 174 thousand LTL (51 thousand EUR). EBITDA..
More